B. Riley analyst Kyle Bauser downgraded the corporate price target on OptimizeRx (OPRX) from $17 to $13 and maintains a purchase ranking on the inventory after the corporate introduced that CEO William Febbo would go away to pursue different alternatives and that its president was named interim CEO whereas the corporate searches a everlasting substitute.
Revealed first on The fly – the last word supply of real-time, up-to-the-minute monetary info and market developments. Try now>>
See the top stocks recommended by analysts >>
Be taught extra about OPRX:
#OptimizeRx #worth #goal #lowered #Riley , #Gossip247
,
rupert murdoch
crypto information
oracle inventory
goog inventory
googl inventory
mondelez
wreaths throughout america
